Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy

Abstract Background Recently, therapeutic antibodies against programmed cell death 1 (PD-1) and its ligand (PD-L1) have exerted potent anticancer effect in a variety of tumors. However, blocking the PD-1/PD-L1 axis alone is not sufficient to restore normal immune response. Other negative regulators...

Full description

Bibliographic Details
Main Authors: Mengke Niu, Ming Yi, Yuze Wu, Lijuan Lyu, Qing He, Rui Yang, Liang Zeng, Jian Shi, Jing Zhang, Pengfei Zhou, Tingting Zhang, Qi Mei, Qian Chu, Kongming Wu
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Hematology & Oncology
Subjects:
TGF-β
VEGF
Bispecific antibody
PD-1
Cancer immunotherapy
The tumor microenvironment
Online Access:https://doi.org/10.1186/s13045-023-01487-5

Internet

https://doi.org/10.1186/s13045-023-01487-5

Similar Items